Molecular MRI for sensitive and specific detection of lung metastases

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 8, 2010, Pages 3693-3697

  Branca, Rosa T ^a   Cleveland, Zackary I ^b   Fubara, Boma ^b   Kumar, Challa S S R ^c   Maronpot, Robert R ^d   Leuschner, Carola ^e   Warren, Warren S ^a   Driehuys, Bastiaan ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Hyperpolarized gas MRI; Luteinizing hormone releasing hormone; Superparamagnetic iron oxide nanoparticles

Indexed keywords

IRON OXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; FEMALE; FERRIC COMPOUNDS; HELIUM; HUMANS; ISOTOPES; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; NANOPARTICLES;

MUS;

EID: 77649255916     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1000386107     Document Type: Article

References (49)

1. American Cancer Society, Cancer facts & Figures 2009, http://www.cancer.org/downloads/STT/500809web.pdf.
2. Engel J, et al. (2003) The process of metastasisation for breast cancer. Eur J Cancer 39: 1794-1806.
3. Hess KR, et al. (2006) Metastatic patterns in adenocarcinoma. Cancer 106:1624-1633.
4. Coleman RE (1999) PET in lung cancer. J Nucl Med 40:814-820.
5. Kennel SJ, et al. (2000) High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology. Med Phys 27:1101-1107.
6. Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683-693.
7. Harris RS, Schuster DP (2007) Visualizing lung function with positron emission tomography. J Appl Physiol 102:448-458.
8. Frush DP, Applegate K (2004) Computed tomography and radiation: understanding the issues. J Am Coll Radiol 1(2):113-119.
9. Deroose CM, et al. (2007) Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. J Nucl Med 48:295-303.
10. Bulte JWM, Brooks RA, Moskowitz BM, Bryant LH, Jr, Frank JA (1999) Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn Reson Med 42: 379-384.
11. Mendonca Dias MH, Lauterbur PC (1986) Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn Reson Med 3:328-330.
12. Bulte JWM, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499.
13. Rogers WJ, Meyer CH, Kramer CM (2006) Technology insight: In vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med 3:554-562.
14. Shapiro EM, et al. (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101:10901-10906.
15. Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur Radiol 11: 2319-2331.
16. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995-4021.
17. Corot C, Robert P, Idée JM, Port M (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58:1471-1504.
18. Brudin LH, Rhodes CG, Valind SO, Wollmer P, Hughes JM (1987) Regional lung density and blood volume in nonsmoking and smoking subjects measured by PET. J Appl Physiol 63:1324-1334.
19. Hatabu H, Alsop DC, Listerud J, Bonnet M, Gefter WB (1999) T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. Eur J Radiol 29:245-252.
20. Kuethe DO, Adolphi NL, Fukushima E (2007) Short data-acquisition times improve projection images of lung tissue. Magn Reson Med 57:1058-1064.
21. van Beek EJR, et al. (2004) Functional MRI of the lung using hyperpolarized 3-helium gas. J Magn Reson Imaging 20:540-554.
22. de Lange EE, et al. (1999) Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology 210:851-857.
23. Salerno M, et al. (2001) Hyperpolarized noble gas MR imaging of the lung: Potential clinical applications. Eur J Radiol 40:33-44.
24. Guenther D, Hanisch G, Kauczor HU (2000) Functional MR imaging of pulmonary ventilation using hyperpolarized noble gases. Acta Radiol 41:519-528.
25. Fain SB, et al. (2007) Functional lung imaging using hyperpolarized gas MRI. J Magn Reson Imaging 25:910-923.
26. Driehuys B, et al. (2007) 3He MRI in mouse models of asthma. Magn Reson Med 58: 893-900.
27. Dugas JP, Garbow JR, Kobayashi DK, Conradi MS (2004) Hyperpolarized (3)He MRI of mouse lung. Magn Reson Med 52:1310-1317.
28. Driehuys B, Hedlund LW (2007) Imaging techniques for small animal models of pulmonary disease: MR microscopy. Toxicol Pathol 35:49-58.
29. Takahashi M, Kubo S, Kiryu S, Gee J, Hatabu H (2007) MR microscopy of the lung in small rodents. Eur J Radiol 64:367-374.
30. Walker TG, Happer W (1997) Spin-exchange optical pumping of noble-gas nuclei. Rev Mod Phys 69:62-642.
31. Mugler JP, et al. (2009) T2* for Hyperpolarized Xe129 in the Healthy Human Lung at 1.5T and 3T. International Society of Magnetic Resonance in Medicine. Seventeenth Meeting Proceedings (ISMRM, Berkeley, CA), p. 2207.
32. Salerno M, Brookeman JR, de Lange EE, Mugler JP, 3rd (2005) Hyperpolarized 3He lung imaging at 0.5 and 1.5 Tesla: A study of susceptibility-induced effects. Magn Reson Med 53:212-216.
33. Pintaske J, Müller-Bierl B, Schick F (2006) Geometry and extension of signal voids in MR images induced by aggregations of magnetically labelled cells. Phys Med Biol 51: 4707-4718.
34. Viallon M, et al. (2000) Laser-polarized (3)He as a probe for dynamic regional measurements of lung perfusion and ventilation using magnetic resonance imaging. Magn Reson Med 44:1-4.
35. Leuschner C, et al. (2006) LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res Treat 99:163-176.
36. Welch DR (1997) Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis 15:272-306.
37. Leuschner C, Enright FM, Gawronska-Kozak B, Hansel W (2003) Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors. Prostate 56:239-249.
38. Shibata S, et al. (2007) The time course of lymphatic routes emanating from the peritoneal cavity in rats. Anat Histol Embryol 36:78-82.
39. Heyn C, Bowen CV, Rutt BK, Foster PJ (2005) Detection threshold of single SPIOlabeled cells with FIESTA. Magn Reson Med 53:312-320.
40. van Beek EJR, Wild JM (2005) Hyperpolarized 3-helium magnetic resonance imaging to probe lung function. Proc Am Thorac Soc 2:528-532, 510.
41. Schally AV, Nagy A (1999) Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Eur J Endocrinol 141:1-14.
42. Zhang C, et al. (2007) Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 67:1555-1562.
43. Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63:2723-2727.
44. Choi H, Choi SR, Zhou R, Kung HF, Chen IW (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11:996-1004.
45. Yang L, et al. (2009) Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 5:235-243.
46. Suzuki M, et al. (2005) Epidermal growth factor receptor expression status in lung cancer correlates with its mutation. Hum Pathol 36:1127-1134.
47. Heyn C, et al. (2006) In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 56:1001-1010.
48. Kumar CS, et al. (2004) Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells. J Nanosci Nanotechnol 4:245-249.
49. Zhou J, Leuschner C, Kumar C, Hormes JF, Soboyejo WO (2006) Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 27:2001-2008.